HRX215
Kwaliteit
ISO Gecertificeerd
Levering
24-48 uur
Technische Specificaties
2369583-33-3
Darizmetinib
C01965-5mg
P38 MAPK
MAPK
HRX215 (Darizmetinib) is a first-in-class, highly potent, selective, and orally active inhibitor of MKK4 with an IC50 of 0.02 μM. It enhances liver regeneration, prevents liver failure following extensive hepatectomy in pigs, and has potential to prevent liver failure after major oncological liver resections or transplantation of small liver grafts in humans.
Beschrijving
HRX215 Beschikbaar in 5 mg. Bestel eenvoudig online met snelle levering.
Specificaties
Recent bekeken producten
Ligation Buffer
LB001
1.4 mL
BioCoupler® x 12
BC12
12 Each
Recombinant Common timothy PHLPIV/Phl p 4 Protein, N-His
YZZ03001
100 μg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03Low – 10 mg
10 mg
NP (4-hydroxy-3-nitrophenylacetate)
NP-BSA-03High – 10 mg
10 mg
ExactaCruz® Pipette Tip Reload System, 50-1250 μl, case
sc-201714
80 Racks/Case
Disc Membrane Hydrophobic PTFE, 0.22μm
CPTB14222
50 PCS
Rat Serum Albumin
CSB-NP000101r-01
1 mg
Recent gezochte producten
NIT2 Human qPCR Primer Pair (NM_020202)
HP213556
200 Reactions
NIT2 (NM_020202) Human Tagged ORF Clone
RC210660
10 µg
Human NIT2 (NM_020202) AAV Particle
RC210660A1V
250 µL
NIT2 (NM_020202) Human Tagged ORF Clone
RG210660
10 µg
NIT2 (NM_020202) Human Untagged Clone
SC108295
10 µg
NIT2 (NM_020202) Human 3' UTR Clone
SC204925
10 µg
LHX9 (NM_020204) Human 3' UTR Clone
SC210775
10 µg
Anti-h ST2 10202 SPTN-5
MBS5680565-01
1 mg